P8-07 QT Interval Prolongation : Project for Database Construction, 1) Standard Protocol, and Inter- and Intra-Facility Differences in APD Assay Using Isolated Guinea Pig Papillary Muscles(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)

Ryuzaburo Yamazaki, Fumio Sagami, Kazuo Kobayashi(Kyushu University), Shinya Taniguchi(Konan University), Takashi Shimosato, Shinichi Kiitani, Chiaki Shimada(Japan Medical Association), Keiji Yamamoto(The University of Osaka), Tatsuya Mori(Kyowa Kirin (Japan)), Masayuki Yamada(Fukushima Medical University), Hideki Suganami(Kowa (Japan))
The Journal of Toxicological Sciences
October 29, 2004
Cited by 0

Related Papers

Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial
|˜The œLancet. Gastroenterology & hepatology|2018|174
Olmesartan Is an Angiotensin II Receptor Blocker with an Inhibitory Effect on Angiotensin-Converting Enzyme
|Hypertension Research|2006|135
The cytolysin gene of Vibrio vulnificus: sequence and relationship to the Vibrio cholerae E1 Tor hemolysin gene
|Infection and Immunity|1990|123
A Homologue ofN-Ethylmaleimide-sensitive Factor in the Malaria ParasitePlasmodium falciparum Is Exported and Localized in Vesicular Structures in the Cytoplasm of Infected Erythrocytes in the Brefeldin A-sensitive Pathway
|Journal of Biological Chemistry|2001|72
Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial
|Journal of Gastroenterology|2017|62